Form 10Q
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                   Quarterly Report Under Section 13 or 15 (d)
                     of the Securities Exchange Act of 1934

For Quarter Ended:          Nov. 30, 1997
                  ------------------------------------

Commission File Number:      0-11050
                       -------------------------------

                              Mammatech Corporation
--------------------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)


           Florida                                            59-2181303
--------------------------------------------------------------------------------
(State or other jurisdiction of                          (I.R.S. Employer
incorporation or organization)                            Identification Number)


930 N.W. 8th Avenue, Gainesville, Florida            32601
--------------------------------------------------------------------------------
(Address of principal executive offices)          (Zip Code)


                                 (904) 375-0607
--------------------------------------------------------------------------------
              (Registrant's telephone number, including area code)


Indicate by check mark whether the registrant (1) has filed all reports required
to be filed  by  section  13 or 15 (d) of the  Securities  Exchange  Act of 1934
during the preceding 12 months (or for such shorter  period that the  registrant
was  required  to file such  reports),  and (2) has been  subject to such filing
requirements for the past ninety days.      Yes     No  X
                                               -----  -----

Indicate the number of shares  outstanding  of each of the  issuer's  classes of
common stock, as of the latest practicable date:

                                          Number of shares outstanding on

                                                   Nov. 30, 1997
                                          --------------------------------------
                                          100,352,500 shares of which
                                          6,208,500 are treasury shares
TITLE OF EACH CLASS
-------------------
Common stock $.0001 par value

The total number of pages of this report is 11.








                                       -1-

<PAGE>






                              Mammatech Corporation

                                      INDEX
--------------------------------------------------------------------------------

PART I.

         FINANCIAL INFORMATION                                PAGE NO.


         Item 1.  Financial Statements

         Statements of Operations for Three Months
         Ended Nov. 30, 1997 and Nov. 30, 1996....................3

         Balance Sheets for Nov. 30, 1997 and
         August 31, 1997........................................4-5

         Statement of Cash Flow for the Quarter
         Ended Nov. 30, 1997......................................6

         Statement of Cash Flow for the Quarter
         Ended Nov. 30, 1997......................................7

         Notes to Financial Statements for the Quarter
         Ended Nov. 30, 1997......................................8


         Item 2.  Management's Discussion and Analysis of
         Financial Conditions and Results of Operations...........9


PART II.     OTHER INFORMATION


         Item 6.  Exhibits and Reports on Form 8-K...............10

         SIGNATURES............................................. 11







                                       -2-

<PAGE>




                              Mammatech Corporation
                            Statements of Operations
                                   (Unaudited)

                                                   Three Months Ended
                                            November, 1997     November, 1996

Sales, net                                   $    175,012       $     97,883

Cost of sales                                $     47,925       $     28,859
                                             ------------       ------------


Gross Profit                                 $    127,087             69,024

Selling, general and
 administrative expense                      $     79,906       $     52,769
                                             ------------       ------------

Operating Income (Loss)                      $     47,181             16,259

Other income
(expense)
Reimbursement (SBIR Grant)                         26,307                  0
 Interest & Dividend Income                         3,830              1,955
                                             ------------       ------------
                                                   30,136              1,955

Net Income before taxes                      $     77,317             18,210
Provision for income taxes                              0                  0
Net Income                                         77,317             18,210




NET INCOME (LOSS)                                  77,317             18,210
                                             ============       ============

Net income (loss) per share                         .0008              .0002
                                             ============       ============

Weighted average shares                       100,352,500        100,352,500
                                             ============       ============



    The accompanying notes are an integral part of the financial statements.






                                       -3-

<PAGE>








                              Mammatech Corporation

                                 Balance Sheets

                                              Nov. 30, 1997    Aug. 31, 1997
                                               (Unaudited)       (Audited)
                                               -----------       ---------


ASSETS
------

  Cash and Cash Equivalents                      $254,584         $169,088
  Available for sale:
         securities                                82,752           82,752
  Accounts receivable:
    Trade                                          46,135           62,745
    Other                                           3,236            3,236

  Inventory                                       166,237          162,019
  Other current assets

  Total Current Assets                            552,944          479,840
  --------------------                           --------         --------

Property and equipment                             53,422           49,082

Other assets:

    Other investments

Patents, trademarks, and
    other intangibles, net of
    accumulated amortization
    of $64,675 and $64,376
    respectively                                    6,032            1,262
                                                 --------         --------

    Total other assets                              6,032            1,262
    ------------------                           --------         --------

TOTAL ASSETS                                     $612,398         $530,184
                                                 ========         ========






    The accompanying notes are an integral part of the financial statements.







                                       -4-

<PAGE>




                              Mammatech Corporation
                                                                 Balance Sheets
                              As of August 31, 1997
                                and Nov. 30, 1997
                                   (continued)

                                                   Nov.1997          Aug. 1997
                                                 ------------      ------------

LIABILITIES AND STOCKHOLDERS' EQUITY
------------------------------------

CURRENT LIABILITIES
-------------------

Current portion of long term debt                       2,704             3,578
Accounts payable-trade                            $    44,239       $    38,722
Customer deposits                                           0                 0
Accrued payable-officer                                 6,630             6,630
Accrued expenses                                       58,623            58,368
                                                  -----------       -----------


TOTAL CURRENT LIABILITIES                             112,196           107,298
                                                  -----------       -----------


COMMITMENTS
  Long term debt                                        5,527             5,527

Stockholders' equity:

  Common stock, par value $.0001;
  200,000,000 shares authorized;
  100,352,500 shares issued
  and outstanding                                 $    10,035       $    10,035

  Additional paid-in capital                        2,809,594         2,809,594
  Accumulated deficit                              (2,183,155)       (2,260,471)
                                                  -----------       -----------

                                                      636,474           559,158

  Valuation allowance: mkt. sec                         6,252             6,252
  Treasury stock at cost,
  6,208,500 shares                                   (148,051)         (148,051)
                                                  -----------       -----------
                                                      494,675           417,359
                                                  -----------       -----------


TOTAL LIABILITIES AND
STOCKHOLDERS' EQUITY                              $   612,398       $   530,184
                                                  ===========       ===========


        The accompanying notes are an integral part of these statements.







                                       -5-

<PAGE>


                              Mammatech Corporation
                             Statement of Cash Flow
                           For the Three Months Ending
                                  Nov. 30, 1997



Net cash flow from operating activities                  $ 81,156
                                                         ========

Investing Activities:

Purchase of fixed assets                                    4,340
Financing activities:
    Issuance of treasury shares                               -0-

Net increase (decrease) in cash                            85,496

         Beginning cash                                   169,088
                                                         --------

Ending cash                                              $254,584
                                                         ========





    The accompanying notes are an integral part of the financial statements.








                                       -6-

<PAGE>

                             Mammatech Corporation
                             Statement of Cash Flow
                          For the Three Months Ending
                                 Nov. 30, 1996



Net cash flow from operating activities                   $ 16,045
                                                          ========

Investing Activities:

Purchase of fixed assets                                     3,000
Financing activities:
    Issuance of treasury shares                                  0

Net increase (decrease) in cash                             19,045

    Beginning cash                                         179,651
                                                          --------

Ending cash                                               $198,696
                                                          ========



    The accompanying notes are an integral part of the financial statements.





                                       -7-

<PAGE>



                              Mammatech Corporation
                          Notes to Financial Statements
                                  Nov. 30, 1997



Note 1. In the  opinion  of the  Company,  the  accompanying
        unaudited financial  statements contain all adjustments
        (consisting of only normal recurring

        accruals) necessary to present fairly the financial
        position as of Nov. 30, 1997, and the results of
        operations and changes in financial position for
        the three months ended Nov. 30, 1997.


Note 2. Loss per  share is  based on the  weighted  average
        number of shares outstanding during each period.

Note 3. Gives effect to the Company's repurchasing 7,558,500
        shares of stock from shareholders for treasury stock.








                             -8-

<PAGE>




MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITIONS AND RESULTS OF OPERATION FOR MAMMATECH CORPORATION



Results  for the  first  quarter  of  Fiscal  1998  are the  second  best in the
Company's  history,  exceeded only by those of the previous  quarter.  Net sales
decreased  5.4% from the  previous  quarter and were 78% greater  than the first
quarter of 1997.  The  operating  costs of $79,906  represents a increase of 27%
relative to the previous  quarter and 19% in  comparison to the same period last
year. The net income for the quarter was 7.9% below that of the previous quarter
but 425% above that of the prior year quarter.

The Company  continued to expand its customer  base during the first  quarter of
1998. The German distributor  launched the product line late in the quarter amid
considerable  national  publicity.   Revenues  from  that  effort  have  yet  to
materialize.  In  addition,  a  distribution  agreement  was  reached  with  the
Brazilian  health  care   organization  with  which  the  Company  had  been  in
negotiations  for  several  months.  A  principal  of that  concern  came to the
Company's  training  center for  intensive  training in the entire  MammaCare(R)
technology.  No  revenues  have yet  resulted  from that  activity  although  an
impressive web site has been  established and the Company is hopeful that future
sales in Brazil  will be  substantial.  A major  portion  of the  first  quarter
revenue  was the result of two  contractors  purchasing  substantial  amounts of
MammaCare(R)  products fur use in conducting training in military  installations
in Europe.

The most  significant  development of the quarter was the launch of the Phase II
SBIR  project   designed  to  validate  the  Company's   adaptive   versions  of
MammaCare(R)  for use by visually or hearing  impaired  women.  The project will
involve  placing  several hundred  individual  learning  systems in the homes of
volunteers  from  these  populations,  then  surveying  them  to  determine  the
acceptability  of the  products.  Although in future  quarters this project will
result in a small number of internal sales of prototype systems, there can be no
assurance that long term enhancement of revenues will result from this research.

With  the  exception  of  a  small  note  to  an  unaffiliated  supplier  for  a
manufacturing  facility,  the  Company  remains  debt free and has no  immediate
liquidity  problems.  It continues to seek a  relationship  with a larger health
care organization.






                                       -9-

<PAGE>



PART II - OTHER INFORMATION
---------------------------




Item 6.    Exhibits and Reports on Form 8-K

   (a.)    Exhibits - None

   (b.)    There were no reports filed on Form 8-K during the three
           months ending Nov. 30, 1997.















                                      -10-

<PAGE>



                                      10-Q

                    For the three months ended Nov. 30, 1997

                                   Signatures

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.

MAMMATECH CORPORATION
---------------------

DATE: ______________________       BY: _______________________________
                                       Henry S. Pennypacker, President
                                       and Director



BY: _______________________________
    Mary Sellers, Treasurer and
    Chief Financial Officer








                                      -11-